Question? Call us
212-363-7500Expired
Lead Plaintiff Deadline
Aug 24, 2021
Choose your preferred way to stay informed of new case launches and settlement deadlines
(1) the research conducted by Defendant Kawas, which formed the foundation for Athira’s product candidates and intellectual property, was tainted by Kawas’ scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.
In order to be eligible to join the ATHA class action lawsuit, you must have incurred a loss on shares of Athira Pharma purchased during the class period listed above.
If you suffered a loss in Athira Pharma during the relevant time frame, you have until August 24, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP